Haoming Lin

2.4k total citations · 1 hit paper
47 papers, 1.8k citations indexed

About

Haoming Lin is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Haoming Lin has authored 47 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Surgery and 15 papers in Oncology. Recurrent topics in Haoming Lin's work include MicroRNA in disease regulation (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Haoming Lin is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Haoming Lin collaborates with scholars based in China, United States and Hong Kong. Haoming Lin's co-authors include Lihong Lv, Changzhen Shang, Min Jun, Xinbing Sui, Tian Xie, Yun-Le Wan, Ting Duan, Mingming Zhang, Xiang Yu and Shuiping Liu and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Hepatology.

In The Last Decade

Haoming Lin

46 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer

2018 546 citations Xinbing Sui, Ruonan Zhang et al. Frontiers in Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haoming Lin China	16	1.1k	784	513	237	200	47	1.8k
Yong Xu China	26	1.1k 1.0×	631 0.8×	404 0.8×	461 1.9×	142 0.7×	83	2.1k
Guishuai Lv China	15	1.3k 1.2×	1.0k 1.3×	180 0.4×	330 1.4×	305 1.5×	18	2.0k
Jiong Bi China	27	1.7k 1.5×	1.0k 1.3×	265 0.5×	594 2.5×	228 1.1×	51	2.5k
Yongfu Zhao China	24	923 0.8×	529 0.7×	158 0.3×	261 1.1×	301 1.5×	60	1.5k
Jun Qian China	19	1.1k 1.0×	936 1.2×	394 0.8×	216 0.9×	122 0.6×	45	1.7k
Ruipeng Song China	22	997 0.9×	651 0.8×	145 0.3×	275 1.2×	113 0.6×	51	1.7k
Xuelai Luo China	29	1.6k 1.4×	768 1.0×	250 0.5×	422 1.8×	394 2.0×	62	2.2k
Changwei Dou China	22	1.2k 1.1×	852 1.1×	245 0.5×	334 1.4×	132 0.7×	46	1.8k
Fei Cao China	20	600 0.5×	306 0.4×	254 0.5×	333 1.4×	248 1.2×	77	1.4k
JiHoon Kang South Korea	21	642 0.6×	476 0.6×	275 0.5×	493 2.1×	100 0.5×	63	1.4k

Countries citing papers authored by Haoming Lin

Since Specialization

Citations

This map shows the geographic impact of Haoming Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoming Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoming Lin more than expected).

Fields of papers citing papers by Haoming Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haoming Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoming Lin. The network helps show where Haoming Lin may publish in the future.

Co-authorship network of co-authors of Haoming Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Haoming Lin. A scholar is included among the top collaborators of Haoming Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haoming Lin. Haoming Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Zhijun, Zhixin Song, Wei Zhang, et al.. (2025). Application of Immune Checkpoint Inhibitors in Cancer. MedComm. 6(8). e70176–e70176. 1 indexed citations

Pang, Li, Lei‐Bo Xu, Zhijun Chen, et al.. (2025). Short-term prognosis of recipients with pretransplant exposure to immune checkpoint inhibitors after liver transplantation for hepatocellular carcinoma: A retrospective cohort study. Liver Research. 9(3). 221–230. 1 indexed citations

Chen, Wei, Haoming Lin, Mengzhen Li, et al.. (2025). High‐velocity impact response and damage behavior of bio‐inspired helicoidal composite laminates: Experimental and numerical investigation. Polymer Composites. 46(10). 9148–9160. 4 indexed citations

Lu, Xinjun, Qi Zhu, Junfeng Cai, et al.. (2024). Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation. Cancer Immunology Immunotherapy. 74(1). 18–18. 3 indexed citations

Yang, Bing, Yanmei Shi, Daning Lu, et al.. (2024). PerturbDB for unraveling gene functions and regulatory networks. Nucleic Acids Research. 53(D1). D1120–D1131. 2 indexed citations

Lin, Haoming, et al.. (2023). Cancer-specific survival in patients with cholangiocarcinoma after radical surgery: a Novel, dynamic nomogram based on clinicopathological features and serum markers. BMC Cancer. 23(1). 533–533. 2 indexed citations

Yang, Kege, Shaojie Chen, Guoda Lian, et al.. (2023). CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification. Journal of Translational Medicine. 21(1). 43–43. 19 indexed citations

Yan, Jian, Gang Xiao, Qinqin Liu, et al.. (2023). Cancer-Associated Fibroblasts Promote Lymphatic Metastasis in Cholangiocarcinoma via the PDGF-BB/PDGFR-β Mediated Paracrine Signaling Network. Aging and Disease. 15(1). 369–369. 23 indexed citations

Liu, Qinqin, Yan‐Fang Ye, Haoming Lin, et al.. (2023). Real-world experience of postoperative adjuvant chemoimmunotherapy in patients with perihilar cholangiocarcinoma at high risk of recurrence. Cancer Immunology Immunotherapy. 72(6). 1753–1761. 2 indexed citations

10.

Yan, Qing, Haoming Lin, Ke Zhu, et al.. (2022). Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma. Frontiers in Oncology. 12. 810269–810269. 21 indexed citations

11.

Qin, Yufei, Haoming Lin, Lei‐Bo Xu, et al.. (2022). Hepatitis B Virus Surface Antigen Promotes Stemness of Hepatocellular Carcinoma through Regulating MicroRNA-203a. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 9 indexed citations

12.

Chen, Wei, Linhua Ji, Jian Wang, et al.. (2021). Screening of a novel autophagy-related prognostic signature and therapeutic targets in hepatocellular carcinoma. Journal of Gastrointestinal Oncology. 12(6). 2985–2998. 6 indexed citations

13.

Chai, Yunfei, Haoming Lin, Chunbo Chen, et al.. (2020). Dihydroquercetin Activates AMPK/Nrf2/HO-1 Signaling in Macrophages and Attenuates Inflammation in LPS-Induced Endotoxemic Mice. Frontiers in Pharmacology. 11. 662–662. 62 indexed citations

14.

Li, Wenbin, Yue Zhu, Kelin Zhang, et al.. (2020). PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer. Experimental & Molecular Medicine. 52(3). 409–422. 30 indexed citations

15.

Lin, Haoming, et al.. (2020). Comprehensive network analysis of the molecular mechanisms associated with sorafenib resistance in hepatocellular carcinoma. Cancer Genetics. 245. 27–34. 10 indexed citations

16.

Zhang, Rui, Haoming Lin, Hong Zeng, et al.. (2019). Clinical strategies for differentiating IgG4-related cholecystitis from gallbladder carcinoma to avoid unnecessary surgical resection. Science China Life Sciences. 63(5). 764–770. 8 indexed citations

17.

Han, Qingfang, Lihong Lv, Jinxing Wei, et al.. (2019). Vps4A mediates the localization and exosome release of β-catenin to inhibit epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Letters. 457. 47–59. 50 indexed citations

18.

Sui, Xinbing, Ruonan Zhang, Shuiping Liu, et al.. (2018). RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer. Frontiers in Pharmacology. 9. 1371–1371. 546 indexed citations breakdown →

19.

Lv, Lihong, Yun-Le Wan, Yan Lin, et al.. (2012). Anticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responses in Vitro. Journal of Biological Chemistry. 287(19). 15874–15885. 381 indexed citations

20.

Yu, Jiandong, et al.. (2011). Donor liver natural killer cells alleviate liver allograft acute rejection in rats. Hepatobiliary & pancreatic diseases international. 10(4). 386–392. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact